Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Palliative Care | 61 | 2024 | 3478 | 4.560 |
Why?
|
Quality of Life | 74 | 2024 | 12730 | 2.400 |
Why?
|
Lung Neoplasms | 48 | 2022 | 13019 | 2.150 |
Why?
|
Gastrointestinal Neoplasms | 14 | 2023 | 987 | 2.010 |
Why?
|
Neoplasms | 56 | 2023 | 21596 | 1.970 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 31 | 2022 | 5171 | 1.810 |
Why?
|
Adaptation, Psychological | 26 | 2024 | 2575 | 1.700 |
Why?
|
Caregivers | 21 | 2023 | 2074 | 1.690 |
Why?
|
Terminal Care | 22 | 2023 | 1688 | 1.600 |
Why?
|
Medication Adherence | 11 | 2024 | 2055 | 1.520 |
Why?
|
Hospice Care | 11 | 2023 | 671 | 1.470 |
Why?
|
Anxiety | 29 | 2023 | 4279 | 1.240 |
Why?
|
Depression | 38 | 2023 | 7733 | 0.980 |
Why?
|
Telemedicine | 4 | 2022 | 2853 | 0.950 |
Why?
|
Affect | 11 | 2019 | 1473 | 0.910 |
Why?
|
Stress, Psychological | 14 | 2022 | 4229 | 0.890 |
Why?
|
Breast Neoplasms | 11 | 2024 | 20774 | 0.730 |
Why?
|
Fatigue | 7 | 2024 | 1526 | 0.650 |
Why?
|
Hematopoietic Stem Cell Transplantation | 12 | 2024 | 5425 | 0.590 |
Why?
|
Drug Therapy | 1 | 2020 | 497 | 0.580 |
Why?
|
Reminder Systems | 1 | 2020 | 370 | 0.570 |
Why?
|
Antineoplastic Agents | 9 | 2022 | 13655 | 0.560 |
Why?
|
Terminally Ill | 3 | 2017 | 238 | 0.560 |
Why?
|
Medical Oncology | 6 | 2021 | 2235 | 0.510 |
Why?
|
Administration, Oral | 7 | 2022 | 3913 | 0.510 |
Why?
|
Middle Aged | 92 | 2024 | 213127 | 0.500 |
Why?
|
Humans | 162 | 2024 | 742088 | 0.490 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2023 | 3497 | 0.480 |
Why?
|
Aged | 76 | 2022 | 162944 | 0.480 |
Why?
|
Patient-Centered Care | 2 | 2022 | 1436 | 0.480 |
Why?
|
Interdisciplinary Communication | 2 | 2018 | 950 | 0.450 |
Why?
|
Hospitalization | 16 | 2024 | 10232 | 0.450 |
Why?
|
Female | 104 | 2024 | 379592 | 0.440 |
Why?
|
Documentation | 3 | 2014 | 865 | 0.430 |
Why?
|
Chemotherapy, Adjuvant | 6 | 2024 | 3471 | 0.420 |
Why?
|
Family | 3 | 2017 | 3144 | 0.410 |
Why?
|
Male | 102 | 2024 | 349538 | 0.410 |
Why?
|
Social Support | 3 | 2020 | 2117 | 0.390 |
Why?
|
Hematologic Neoplasms | 6 | 2024 | 1820 | 0.390 |
Why?
|
Anxiety Disorders | 3 | 2012 | 2684 | 0.380 |
Why?
|
Advance Care Planning | 5 | 2020 | 660 | 0.380 |
Why?
|
Interpersonal Relations | 2 | 2018 | 1423 | 0.380 |
Why?
|
Dyspnea | 2 | 2015 | 1298 | 0.370 |
Why?
|
Patient Satisfaction | 6 | 2022 | 3391 | 0.370 |
Why?
|
Behavior Therapy | 1 | 2015 | 866 | 0.350 |
Why?
|
Physician-Patient Relations | 6 | 2022 | 3215 | 0.340 |
Why?
|
Patient Participation | 2 | 2018 | 1445 | 0.340 |
Why?
|
Randomized Controlled Trials as Topic | 13 | 2024 | 9941 | 0.340 |
Why?
|
Pilot Projects | 13 | 2024 | 8297 | 0.330 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2021 | 4248 | 0.330 |
Why?
|
Survivors | 3 | 2021 | 2286 | 0.330 |
Why?
|
Aged, 80 and over | 31 | 2021 | 57683 | 0.320 |
Why?
|
Attitude to Health | 4 | 2014 | 2051 | 0.320 |
Why?
|
Delivery of Health Care, Integrated | 4 | 2018 | 941 | 0.310 |
Why?
|
Clinical Protocols | 1 | 2014 | 1459 | 0.310 |
Why?
|
Ambulatory Care | 5 | 2022 | 2706 | 0.300 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2022 | 11472 | 0.290 |
Why?
|
Cost of Illness | 5 | 2022 | 1852 | 0.280 |
Why?
|
Self Report | 6 | 2022 | 3548 | 0.270 |
Why?
|
Adult | 48 | 2022 | 213712 | 0.270 |
Why?
|
Feasibility Studies | 9 | 2021 | 5062 | 0.260 |
Why?
|
Professional-Patient Relations | 4 | 2018 | 736 | 0.260 |
Why?
|
Health Personnel | 1 | 2018 | 3210 | 0.250 |
Why?
|
End Stage Liver Disease | 2 | 2019 | 314 | 0.250 |
Why?
|
Patient Compliance | 2 | 2021 | 2680 | 0.250 |
Why?
|
Sarcopenia | 2 | 2021 | 368 | 0.240 |
Why?
|
Communication | 6 | 2022 | 3728 | 0.240 |
Why?
|
Cultural Diversity | 1 | 2007 | 358 | 0.230 |
Why?
|
Somatoform Disorders | 2 | 2014 | 423 | 0.220 |
Why?
|
Antineoplastic Agents, Hormonal | 4 | 2024 | 1509 | 0.210 |
Why?
|
Hospices | 3 | 2020 | 264 | 0.200 |
Why?
|
Combined Modality Therapy | 4 | 2022 | 8621 | 0.200 |
Why?
|
Health Status | 2 | 2017 | 4030 | 0.200 |
Why?
|
Outpatients | 3 | 2014 | 1483 | 0.190 |
Why?
|
Treatment Outcome | 16 | 2022 | 62966 | 0.190 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 3014 | 0.180 |
Why?
|
Disease | 1 | 2006 | 681 | 0.180 |
Why?
|
Patients | 3 | 2022 | 892 | 0.180 |
Why?
|
Prognosis | 15 | 2023 | 29010 | 0.180 |
Why?
|
Massachusetts | 4 | 2021 | 8662 | 0.170 |
Why?
|
Graft vs Host Disease | 2 | 2024 | 2951 | 0.170 |
Why?
|
Primary Health Care | 4 | 2012 | 4551 | 0.170 |
Why?
|
Tape Recording | 1 | 2018 | 76 | 0.170 |
Why?
|
Attitude | 2 | 2019 | 772 | 0.160 |
Why?
|
Attitude of Health Personnel | 4 | 2019 | 3839 | 0.160 |
Why?
|
Neoplasm Metastasis | 7 | 2015 | 4839 | 0.160 |
Why?
|
Mental Disorders | 3 | 2022 | 6587 | 0.160 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15530 | 0.160 |
Why?
|
Patient Readmission | 3 | 2022 | 3111 | 0.160 |
Why?
|
Goals | 2 | 2020 | 705 | 0.160 |
Why?
|
Neoplasm Staging | 7 | 2019 | 11001 | 0.150 |
Why?
|
Trauma, Nervous System | 1 | 2017 | 36 | 0.150 |
Why?
|
Nursing Methodology Research | 1 | 2017 | 67 | 0.150 |
Why?
|
Clinical Competence | 2 | 2017 | 4681 | 0.150 |
Why?
|
Personal Satisfaction | 1 | 2022 | 634 | 0.150 |
Why?
|
Resuscitation Orders | 2 | 2017 | 267 | 0.150 |
Why?
|
Androgen Antagonists | 2 | 2021 | 1350 | 0.150 |
Why?
|
Glioma | 2 | 2022 | 3388 | 0.150 |
Why?
|
Cytarabine | 1 | 2019 | 684 | 0.150 |
Why?
|
Electronic Health Records | 6 | 2019 | 4440 | 0.150 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1000 | 0.150 |
Why?
|
Anthracyclines | 1 | 2019 | 288 | 0.140 |
Why?
|
Self Efficacy | 1 | 2020 | 610 | 0.140 |
Why?
|
Death | 1 | 2021 | 675 | 0.140 |
Why?
|
Psychological Tests | 1 | 2018 | 648 | 0.140 |
Why?
|
Uncertainty | 1 | 2021 | 725 | 0.140 |
Why?
|
Actigraphy | 1 | 2019 | 488 | 0.130 |
Why?
|
Patient Advocacy | 1 | 2018 | 353 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2019 | 3915 | 0.130 |
Why?
|
Illness Behavior | 1 | 2014 | 22 | 0.130 |
Why?
|
Physical Fitness | 1 | 2019 | 732 | 0.130 |
Why?
|
Secondary Prevention | 2 | 2019 | 1520 | 0.130 |
Why?
|
Attitude to Death | 1 | 2017 | 382 | 0.120 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2018 | 357 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2019 | 1184 | 0.120 |
Why?
|
Decision Making | 5 | 2021 | 3869 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2022 | 5249 | 0.120 |
Why?
|
Length of Stay | 5 | 2022 | 6294 | 0.120 |
Why?
|
Survival Analysis | 6 | 2021 | 10248 | 0.120 |
Why?
|
Professional Role | 2 | 2014 | 306 | 0.120 |
Why?
|
Pandemics | 3 | 2022 | 8328 | 0.120 |
Why?
|
Patient Education as Topic | 3 | 2019 | 2275 | 0.110 |
Why?
|
Time Factors | 12 | 2019 | 40054 | 0.110 |
Why?
|
Health Care Surveys | 2 | 2019 | 2451 | 0.110 |
Why?
|
Depressive Disorder, Major | 5 | 2014 | 4628 | 0.110 |
Why?
|
United States | 11 | 2021 | 69693 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1369 | 0.110 |
Why?
|
Peer Group | 1 | 2017 | 635 | 0.110 |
Why?
|
Inpatients | 5 | 2024 | 2495 | 0.110 |
Why?
|
Disease Progression | 3 | 2022 | 13256 | 0.110 |
Why?
|
Boston | 3 | 2021 | 9305 | 0.100 |
Why?
|
Activities of Daily Living | 2 | 2019 | 2414 | 0.100 |
Why?
|
Longitudinal Studies | 6 | 2019 | 13921 | 0.100 |
Why?
|
Internship and Residency | 3 | 2017 | 5774 | 0.100 |
Why?
|
Socioeconomic Factors | 4 | 2019 | 7770 | 0.100 |
Why?
|
Cultural Competency | 2 | 2019 | 288 | 0.100 |
Why?
|
Clinical Coding | 1 | 2013 | 171 | 0.100 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2017 | 6030 | 0.100 |
Why?
|
Young Adult | 9 | 2021 | 56350 | 0.100 |
Why?
|
Geriatrics | 1 | 2015 | 396 | 0.100 |
Why?
|
Withholding Treatment | 1 | 2015 | 598 | 0.090 |
Why?
|
Panic Disorder | 1 | 2014 | 616 | 0.090 |
Why?
|
Qualitative Research | 5 | 2019 | 2680 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2022 | 2723 | 0.090 |
Why?
|
Prospective Studies | 15 | 2022 | 53187 | 0.090 |
Why?
|
Teaching | 1 | 2017 | 1174 | 0.090 |
Why?
|
Emotions | 1 | 2022 | 2657 | 0.090 |
Why?
|
Referral and Consultation | 4 | 2020 | 3527 | 0.090 |
Why?
|
Research | 1 | 2017 | 1999 | 0.080 |
Why?
|
Phobic Disorders | 1 | 2011 | 439 | 0.080 |
Why?
|
Grief | 2 | 2012 | 247 | 0.080 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 24913 | 0.080 |
Why?
|
Patient Discharge | 2 | 2020 | 3300 | 0.080 |
Why?
|
Depressive Disorder | 2 | 2012 | 3748 | 0.080 |
Why?
|
Psychometrics | 4 | 2021 | 2999 | 0.080 |
Why?
|
Lung | 3 | 2023 | 9826 | 0.080 |
Why?
|
Internal Medicine | 3 | 2017 | 1009 | 0.080 |
Why?
|
Marriage | 2 | 2007 | 338 | 0.080 |
Why?
|
Interview, Psychological | 1 | 2011 | 812 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2022 | 2712 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2019 | 2117 | 0.080 |
Why?
|
Regression Analysis | 1 | 2018 | 6452 | 0.080 |
Why?
|
Tosyl Compounds | 1 | 2008 | 110 | 0.080 |
Why?
|
Family Practice | 2 | 2008 | 516 | 0.080 |
Why?
|
Transplantation Conditioning | 1 | 2014 | 1597 | 0.080 |
Why?
|
Evidence-Based Practice | 1 | 2012 | 500 | 0.080 |
Why?
|
Widowhood | 1 | 2007 | 54 | 0.070 |
Why?
|
Data Collection | 3 | 2011 | 3339 | 0.070 |
Why?
|
Physicians, Family | 1 | 2008 | 345 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2017 | 5310 | 0.070 |
Why?
|
Hospitals, State | 1 | 2005 | 29 | 0.070 |
Why?
|
Perception | 3 | 2020 | 1188 | 0.070 |
Why?
|
Immunotherapy | 2 | 2021 | 4414 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2838 | 0.070 |
Why?
|
Leuprolide | 1 | 2008 | 303 | 0.070 |
Why?
|
Odds Ratio | 3 | 2019 | 9846 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3070 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2011 | 2970 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4933 | 0.070 |
Why?
|
Program Evaluation | 2 | 2017 | 2485 | 0.070 |
Why?
|
Self Care | 2 | 2022 | 786 | 0.070 |
Why?
|
Critical Illness | 2 | 2020 | 2665 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3510 | 0.060 |
Why?
|
Anilides | 1 | 2008 | 404 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2493 | 0.060 |
Why?
|
Health Expenditures | 1 | 2017 | 2346 | 0.060 |
Why?
|
Hospitals, Psychiatric | 1 | 2005 | 332 | 0.060 |
Why?
|
Object Attachment | 1 | 2007 | 313 | 0.060 |
Why?
|
Neutropenia | 1 | 2008 | 891 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2022 | 19862 | 0.060 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11039 | 0.060 |
Why?
|
Sexual Behavior | 2 | 2018 | 2050 | 0.060 |
Why?
|
Melanoma | 1 | 2021 | 5462 | 0.060 |
Why?
|
Probability | 1 | 2008 | 2502 | 0.050 |
Why?
|
Bereavement | 1 | 2007 | 273 | 0.050 |
Why?
|
Nitriles | 1 | 2008 | 952 | 0.050 |
Why?
|
Comorbidity | 3 | 2012 | 10372 | 0.050 |
Why?
|
Parent-Child Relations | 1 | 2007 | 747 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2023 | 8829 | 0.050 |
Why?
|
Exercise Therapy | 1 | 2009 | 904 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5304 | 0.050 |
Why?
|
Logistic Models | 2 | 2020 | 13403 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2017 | 4369 | 0.050 |
Why?
|
Office Visits | 1 | 2006 | 598 | 0.050 |
Why?
|
Gynecology | 1 | 2007 | 509 | 0.050 |
Why?
|
Interdisciplinary Studies | 1 | 2021 | 89 | 0.050 |
Why?
|
Focus Groups | 2 | 2017 | 1320 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 5979 | 0.050 |
Why?
|
Prevalence | 3 | 2014 | 15194 | 0.050 |
Why?
|
Models, Psychological | 2 | 2020 | 810 | 0.050 |
Why?
|
Leucovorin | 1 | 2022 | 624 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4929 | 0.050 |
Why?
|
Mass Screening | 2 | 2014 | 5238 | 0.050 |
Why?
|
Obstetrics | 1 | 2007 | 657 | 0.050 |
Why?
|
Karnofsky Performance Status | 1 | 2020 | 173 | 0.040 |
Why?
|
Social Work | 1 | 2021 | 162 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2009 | 2455 | 0.040 |
Why?
|
Family Health | 2 | 2016 | 1282 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9185 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1661 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14720 | 0.040 |
Why?
|
Homosexuality, Male | 1 | 2006 | 1238 | 0.040 |
Why?
|
Schizophrenia | 1 | 2017 | 6874 | 0.040 |
Why?
|
Mexico | 1 | 2020 | 688 | 0.040 |
Why?
|
Urban Population | 1 | 2006 | 2018 | 0.040 |
Why?
|
Hyoid Bone | 1 | 1977 | 38 | 0.040 |
Why?
|
New England | 1 | 2020 | 1021 | 0.040 |
Why?
|
Fluorouracil | 1 | 2022 | 1615 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10578 | 0.040 |
Why?
|
Intestinal Polyps | 1 | 1977 | 99 | 0.040 |
Why?
|
Risk Factors | 5 | 2019 | 72145 | 0.040 |
Why?
|
Communicable Diseases | 1 | 2005 | 878 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2007 | 2266 | 0.040 |
Why?
|
Analgesics, Opioid | 1 | 2013 | 3667 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2283 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2020 | 77098 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39004 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10943 | 0.030 |
Why?
|
Pediatrics | 2 | 2008 | 3462 | 0.030 |
Why?
|
Age Factors | 4 | 2015 | 18355 | 0.030 |
Why?
|
Forecasting | 1 | 2004 | 2948 | 0.030 |
Why?
|
Genotype | 3 | 2017 | 12946 | 0.030 |
Why?
|
Physician Assistants | 1 | 2017 | 193 | 0.030 |
Why?
|
Waiting Lists | 1 | 2019 | 692 | 0.030 |
Why?
|
Chondrosarcoma | 1 | 1977 | 309 | 0.030 |
Why?
|
Health Communication | 1 | 2017 | 213 | 0.030 |
Why?
|
Nurse Practitioners | 1 | 2017 | 270 | 0.030 |
Why?
|
Primary Myelofibrosis | 1 | 2015 | 214 | 0.030 |
Why?
|
Feedback | 1 | 2017 | 793 | 0.030 |
Why?
|
Linear Models | 2 | 2016 | 5948 | 0.030 |
Why?
|
Mental Health Services | 1 | 2004 | 1643 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1977 | 600 | 0.030 |
Why?
|
Hospitalists | 1 | 2017 | 304 | 0.030 |
Why?
|
Patient Preference | 1 | 2020 | 886 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 5522 | 0.030 |
Why?
|
Family Relations | 1 | 2014 | 321 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1618 | 0.030 |
Why?
|
Patient Care Team | 2 | 2017 | 2527 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2017 | 921 | 0.030 |
Why?
|
Smoking | 1 | 2008 | 8969 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1503 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1146 | 0.020 |
Why?
|
Social Behavior | 2 | 2009 | 1128 | 0.020 |
Why?
|
Electronic Mail | 1 | 2013 | 213 | 0.020 |
Why?
|
HIV Infections | 2 | 2008 | 16678 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2123 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7276 | 0.020 |
Why?
|
Educational Status | 1 | 2017 | 2533 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2017 | 974 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2013 | 965 | 0.020 |
Why?
|
Physicians | 1 | 2007 | 4554 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3612 | 0.020 |
Why?
|
Methylmethacrylates | 1 | 1989 | 72 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 7901 | 0.020 |
Why?
|
United States Health Resources and Services Administration | 1 | 2008 | 17 | 0.020 |
Why?
|
Truth Disclosure | 1 | 2013 | 435 | 0.020 |
Why?
|
Centrifugation | 1 | 1989 | 122 | 0.020 |
Why?
|
Awareness | 1 | 2013 | 639 | 0.020 |
Why?
|
Medical Records | 1 | 2014 | 1413 | 0.020 |
Why?
|
Training Support | 1 | 2008 | 113 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3740 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2013 | 1342 | 0.020 |
Why?
|
Risk Assessment | 3 | 2017 | 23320 | 0.020 |
Why?
|
Program Development | 1 | 2014 | 1314 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2014 | 2536 | 0.020 |
Why?
|
Leukemia | 1 | 2015 | 1507 | 0.020 |
Why?
|
Pain | 1 | 2022 | 4961 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4771 | 0.020 |
Why?
|
Critical Care | 1 | 2020 | 2640 | 0.020 |
Why?
|
Psychotherapy, Brief | 1 | 2008 | 114 | 0.020 |
Why?
|
Bone Cements | 1 | 1989 | 325 | 0.020 |
Why?
|
Cause of Death | 1 | 2017 | 3571 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2749 | 0.020 |
Why?
|
Lymphoma | 1 | 2015 | 1873 | 0.020 |
Why?
|
Survival Rate | 2 | 2013 | 12773 | 0.020 |
Why?
|
Cohort Studies | 3 | 2017 | 40450 | 0.020 |
Why?
|
Sex Factors | 2 | 2012 | 10392 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7645 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1351 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 1977 | 2542 | 0.020 |
Why?
|
Professional Competence | 1 | 2008 | 448 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2015 | 2585 | 0.020 |
Why?
|
Financing, Government | 1 | 2008 | 468 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 1977 | 2522 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4982 | 0.020 |
Why?
|
Curriculum | 1 | 2017 | 3589 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2450 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 3058 | 0.010 |
Why?
|
Quinazolines | 1 | 2009 | 1355 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2008 | 2030 | 0.010 |
Why?
|
Employment | 1 | 2009 | 1124 | 0.010 |
Why?
|
Mental Health | 1 | 2016 | 2997 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3151 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9679 | 0.010 |
Why?
|
Risk-Taking | 1 | 2006 | 986 | 0.010 |
Why?
|
Mental Recall | 1 | 2007 | 1205 | 0.010 |
Why?
|
India | 1 | 2006 | 2187 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7716 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6534 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2022 | 15244 | 0.010 |
Why?
|
Health Surveys | 1 | 2009 | 4030 | 0.010 |
Why?
|
Adolescent | 2 | 2004 | 85649 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2015 | 5169 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12344 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 20928 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 12958 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6754 | 0.010 |
Why?
|
Lipoma | 1 | 1977 | 334 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2009 | 21719 | 0.010 |
Why?
|
Syndrome | 1 | 1977 | 3248 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17400 | 0.010 |
Why?
|
Methylmethacrylate | 1 | 1989 | 44 | 0.010 |
Why?
|
Freezing | 1 | 1989 | 303 | 0.000 |
Why?
|
Tensile Strength | 1 | 1989 | 334 | 0.000 |
Why?
|
Joint Prosthesis | 1 | 1989 | 257 | 0.000 |
Why?
|
Mutation | 1 | 2011 | 29717 | 0.000 |
Why?
|
Prosthesis Failure | 1 | 1989 | 1203 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1977 | 6347 | 0.000 |
Why?
|